118 related articles for article (PubMed ID: 10694931)
1. Inter-species comparison of microsomal reductive transformation of biologically active benfluron N-oxide.
Skálová L; Nobilis M; Szotáková B; Wsól V; Kvasnicková E
Drug Metabol Drug Interact; 1998; 14(4):235-50. PubMed ID: 10694931
[TBL] [Abstract][Full Text] [Related]
2. Induction and inhibition of cytochrome P450-catalysed reduction of biologically active benfluron N-oxide.
Skálová L; Nobilis M; Szotáková B; Wsól V; Kvasnicková E
Drug Metabol Drug Interact; 1998; 14(4):221-33. PubMed ID: 10694930
[TBL] [Abstract][Full Text] [Related]
3. Effect of substituents on microsomal reduction of benzo(c)fluorene N-oxides.
Skálová L; Nobilis M; Szotáková B; Wsól V; Kubícek V; Baliharová V; Kvasnicková E
Chem Biol Interact; 2000 Jun; 126(3):185-200. PubMed ID: 10862817
[TBL] [Abstract][Full Text] [Related]
4. Use of chiral liquid chromatography for the evaluation of stereospecificity in the carbonyl reduction of potential benzo[c]fluorene antineoplastics benfluron and dimefluron in various species.
Kucera R; Nobilis M; Skálová L; Szotáková B; Císar P; Jira T; Klimes J; Wsól V
J Pharm Biomed Anal; 2005 Apr; 37(5):1049-57. PubMed ID: 15862685
[TBL] [Abstract][Full Text] [Related]
5. Species differences in pulmonary N-oxidation of chlorpromazine and imipramine.
Ohmiya Y; Mehendale HM
Pharmacology; 1984; 28(5):289-95. PubMed ID: 6728903
[TBL] [Abstract][Full Text] [Related]
6. In vitro biotransformation of a novel antimalarial cysteine protease inhibitor in human liver microsomes.
Zhang Y; Guo X; Lin ET; Benet LZ
Pharmacology; 1999 Mar; 58(3):147-59. PubMed ID: 9925971
[TBL] [Abstract][Full Text] [Related]
7. Metabolic pathways of flobufen-a new antirheumatic and antiarthritic drug. Interspecies comparison.
Kvasnicková E; Szotáková B; Wsól V; Trejtnar F; Skálová L; Hais IM; Kuchar M; Poppová M
Exp Toxicol Pathol; 1999 Jul; 51(4-5):352-6. PubMed ID: 10445396
[TBL] [Abstract][Full Text] [Related]
8. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase.
Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH
Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579
[TBL] [Abstract][Full Text] [Related]
9. Enzymology of the reductive bioactivation of SR 4233. A novel benzotriazine di-N-oxide hypoxic cell cytotoxin.
Walton MI; Workman P
Biochem Pharmacol; 1990 Jun; 39(11):1735-42. PubMed ID: 2344370
[TBL] [Abstract][Full Text] [Related]
10. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2.
Stiborová M; Frei E; Wiessler M; Schmeiser HH
Chem Res Toxicol; 2001 Aug; 14(8):1128-37. PubMed ID: 11511187
[TBL] [Abstract][Full Text] [Related]
11. Catalytic activity and substrate specificity of the flavin-containing monooxygenase in microsomal systems: characterization of the hepatic, pulmonary and renal enzymes of the mouse, rabbit, and rat.
Tynes RE; Hodgson E
Arch Biochem Biophys; 1985 Jul; 240(1):77-93. PubMed ID: 3925885
[TBL] [Abstract][Full Text] [Related]
12. Study of the biotransformation of benfluron using the isolated perfused rat liver.
Svoboda Z; Nobilis M; Kvĕtina J; Lemr K
Acta Medica (Hradec Kralove); 1999; 42(2):73-8. PubMed ID: 10596420
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 dependent N-hydroxylation of a guanidine (debrisoquine), microsomal catalysed reduction and further oxidation of the N-hydroxy-guanidine metabolite to the urea derivative. Similarity with the oxidation of arginine to citrulline and nitric oxide.
Clement B; Schultze-Mosgau MH; Wohlers H
Biochem Pharmacol; 1993 Dec; 46(12):2249-67. PubMed ID: 8274159
[TBL] [Abstract][Full Text] [Related]
14. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T
Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855
[TBL] [Abstract][Full Text] [Related]
15. A comparison between stereospecificity of oracin reduction and stereoselectivity of oxidation of 11-dihydrooracin enantiomers in vitro in rat and guinea pig.
Skálová L; Wsól V; Szotáková B; Kvasnicková E
Chirality; 1999; 11(5-6):510-5. PubMed ID: 10368925
[TBL] [Abstract][Full Text] [Related]
16. In vitro biotransformation and investigation of metabolic enzymes possibly responsible for the metabolism of bisdesoxyolaquindox in the liver fractions of rats, chicken, and pigs.
Liu ZY; Chen DM; Huang LL; Tao YF; Yao M; Yuan ZH
Toxicology; 2011 Jan; 279(1-3):155-66. PubMed ID: 20955753
[TBL] [Abstract][Full Text] [Related]
17. The oxidation of ebselen metabolites to thiol oxidants catalyzed by liver microsomes and perfused rat liver.
Akerboom TP; Sies H; Ziegler DM
Arch Biochem Biophys; 1995 Jan; 316(1):220-6. PubMed ID: 7840620
[TBL] [Abstract][Full Text] [Related]
18. In vitro hepatic metabolism of cediranib, a potent vascular endothelial growth factor tyrosine kinase inhibitor: interspecies comparison and human enzymology.
Schulz-Utermoehl T; Spear M; Pollard CR; Pattison C; Rollison H; Sarda S; Ward M; Bushby N; Jordan A; Harrison M
Drug Metab Dispos; 2010 Oct; 38(10):1688-97. PubMed ID: 20634336
[TBL] [Abstract][Full Text] [Related]
19. Species differences in the toxicity and cytochrome P450 IIIA-dependent metabolism of digitoxin.
Eberhart DC; Gemzik B; Halvorson MR; Parkinson A
Mol Pharmacol; 1991 Nov; 40(5):859-67. PubMed ID: 1944247
[TBL] [Abstract][Full Text] [Related]
20. Oxidative and reductive metabolism of tris(p-carboxyltetrathiaaryl)methyl radicals by liver microsomes.
Decroos C; Li Y; Bertho G; Frapart Y; Mansuy D; Boucher JL
Chem Res Toxicol; 2009 Jul; 22(7):1342-50. PubMed ID: 19545126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
